nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—HTR2C—choroid plexus—malignant glioma	0.101	0.165	CbGeAlD
Propiomazine—HTR2A—choroid plexus—malignant glioma	0.0504	0.0829	CbGeAlD
Propiomazine—DRD1—telencephalic ventricle—malignant glioma	0.0379	0.0623	CbGeAlD
Propiomazine—HTR2C—telencephalic ventricle—malignant glioma	0.0295	0.0484	CbGeAlD
Propiomazine—HTR2A—cerebellar cortex—malignant glioma	0.0254	0.0418	CbGeAlD
Propiomazine—DRD2—telencephalic ventricle—malignant glioma	0.0224	0.0368	CbGeAlD
Propiomazine—HTR2A—pons—malignant glioma	0.018	0.0295	CbGeAlD
Propiomazine—HTR2A—vertebral column—malignant glioma	0.0178	0.0293	CbGeAlD
Propiomazine—HTR2A—telencephalic ventricle—malignant glioma	0.0148	0.0243	CbGeAlD
Propiomazine—HTR2A—pineal body—malignant glioma	0.0128	0.0211	CbGeAlD
Propiomazine—DRD1—brainstem—malignant glioma	0.0103	0.0169	CbGeAlD
Propiomazine—Trifluoperazine—CALY—malignant glioma	0.00959	0.332	CrCbGaD
Propiomazine—ADRA1D—telencephalon—malignant glioma	0.00956	0.0157	CbGeAlD
Propiomazine—DRD1—telencephalon—malignant glioma	0.00911	0.015	CbGeAlD
Propiomazine—DRD4—brain—malignant glioma	0.00816	0.0134	CbGeAlD
Propiomazine—HTR2C—brainstem—malignant glioma	0.00797	0.0131	CbGeAlD
Propiomazine—HTR2A—endothelium—malignant glioma	0.00793	0.013	CbGeAlD
Propiomazine—CHRM4—central nervous system—malignant glioma	0.00778	0.0128	CbGeAlD
Propiomazine—CHRM2—telencephalon—malignant glioma	0.00734	0.0121	CbGeAlD
Propiomazine—HTR2A—blood vessel—malignant glioma	0.00732	0.012	CbGeAlD
Propiomazine—HTR2C—telencephalon—malignant glioma	0.00707	0.0116	CbGeAlD
Propiomazine—CHRM1—telencephalon—malignant glioma	0.00668	0.011	CbGeAlD
Propiomazine—DRD1—midbrain—malignant glioma	0.00654	0.0108	CbGeAlD
Propiomazine—ADRA1A—brainstem—malignant glioma	0.00619	0.0102	CbGeAlD
Propiomazine—CHRM4—brain—malignant glioma	0.00617	0.0101	CbGeAlD
Propiomazine—CHRM5—central nervous system—malignant glioma	0.00608	0.00999	CbGeAlD
Propiomazine—DRD2—brainstem—malignant glioma	0.00606	0.00997	CbGeAlD
Propiomazine—CHRM3—telencephalon—malignant glioma	0.00598	0.00983	CbGeAlD
Propiomazine—DRD2—retina—malignant glioma	0.00585	0.00961	CbGeAlD
Propiomazine—HTR2C—medulla oblongata—malignant glioma	0.00556	0.00914	CbGeAlD
Propiomazine—ADRA1B—central nervous system—malignant glioma	0.00555	0.00913	CbGeAlD
Propiomazine—ADRA1A—telencephalon—malignant glioma	0.00549	0.00902	CbGeAlD
Propiomazine—ADRA1D—central nervous system—malignant glioma	0.00543	0.00893	CbGeAlD
Propiomazine—DRD2—telencephalon—malignant glioma	0.00538	0.00884	CbGeAlD
Propiomazine—DRD1—central nervous system—malignant glioma	0.00518	0.00851	CbGeAlD
Propiomazine—HTR2C—midbrain—malignant glioma	0.00508	0.00835	CbGeAlD
Propiomazine—HTR2C—spinal cord—malignant glioma	0.00496	0.00815	CbGeAlD
Propiomazine—CHRM5—brain—malignant glioma	0.00483	0.00793	CbGeAlD
Propiomazine—ADRA1B—brain—malignant glioma	0.00441	0.00725	CbGeAlD
Propiomazine—HTR2A—embryo—malignant glioma	0.00436	0.00717	CbGeAlD
Propiomazine—ADRA1D—brain—malignant glioma	0.00431	0.00709	CbGeAlD
Propiomazine—HRH1—telencephalon—malignant glioma	0.00425	0.00698	CbGeAlD
Propiomazine—CHRM2—central nervous system—malignant glioma	0.00417	0.00686	CbGeAlD
Propiomazine—DRD1—brain—malignant glioma	0.00411	0.00676	CbGeAlD
Propiomazine—HTR2C—central nervous system—malignant glioma	0.00402	0.00661	CbGeAlD
Propiomazine—HTR2A—brainstem—malignant glioma	0.004	0.00657	CbGeAlD
Propiomazine—DRD2—midbrain—malignant glioma	0.00386	0.00635	CbGeAlD
Propiomazine—HTR2A—retina—malignant glioma	0.00386	0.00634	CbGeAlD
Propiomazine—CHRM1—central nervous system—malignant glioma	0.0038	0.00624	CbGeAlD
Propiomazine—HTR2A—telencephalon—malignant glioma	0.00355	0.00583	CbGeAlD
Propiomazine—CHRM3—central nervous system—malignant glioma	0.0034	0.00559	CbGeAlD
Propiomazine—CHRM2—brain—malignant glioma	0.00331	0.00544	CbGeAlD
Propiomazine—HTR2C—brain—malignant glioma	0.00319	0.00525	CbGeAlD
Propiomazine—ADRA1A—central nervous system—malignant glioma	0.00312	0.00513	CbGeAlD
Propiomazine—DRD2—central nervous system—malignant glioma	0.00306	0.00503	CbGeAlD
Propiomazine—ADRA1A—cerebellum—malignant glioma	0.00305	0.00501	CbGeAlD
Propiomazine—CHRM1—brain—malignant glioma	0.00301	0.00496	CbGeAlD
Propiomazine—DRD2—cerebellum—malignant glioma	0.00299	0.00491	CbGeAlD
Propiomazine—HTR2A—medulla oblongata—malignant glioma	0.00279	0.00458	CbGeAlD
Propiomazine—Ethopropazine—BCHE—malignant glioma	0.00271	0.0939	CrCbGaD
Propiomazine—CHRM3—brain—malignant glioma	0.0027	0.00443	CbGeAlD
Propiomazine—HTR2A—midbrain—malignant glioma	0.00255	0.00419	CbGeAlD
Propiomazine—HTR2A—spinal cord—malignant glioma	0.00249	0.00409	CbGeAlD
Propiomazine—ADRA1A—brain—malignant glioma	0.00248	0.00407	CbGeAlD
Propiomazine—DRD2—brain—malignant glioma	0.00243	0.00399	CbGeAlD
Propiomazine—HRH1—central nervous system—malignant glioma	0.00242	0.00397	CbGeAlD
Propiomazine—Clomipramine—GSTP1—malignant glioma	0.00228	0.0788	CrCbGaD
Propiomazine—Methadone—CYP2C18—malignant glioma	0.00225	0.0779	CrCbGaD
Propiomazine—Perphenazine—CYP2C18—malignant glioma	0.00223	0.0772	CrCbGaD
Propiomazine—Triflupromazine—BCHE—malignant glioma	0.00222	0.0769	CrCbGaD
Propiomazine—HTR2A—central nervous system—malignant glioma	0.00202	0.00332	CbGeAlD
Propiomazine—HTR2A—cerebellum—malignant glioma	0.00197	0.00324	CbGeAlD
Propiomazine—HRH1—brain—malignant glioma	0.00192	0.00315	CbGeAlD
Propiomazine—Promethazine—CYP2B6—malignant glioma	0.0017	0.0587	CrCbGaD
Propiomazine—Methadone—CYP2B6—malignant glioma	0.00167	0.0578	CrCbGaD
Propiomazine—Perphenazine—CYP2B6—malignant glioma	0.00166	0.0573	CrCbGaD
Propiomazine—HTR2A—brain—malignant glioma	0.0016	0.00263	CbGeAlD
Propiomazine—Trimipramine—SLC6A3—malignant glioma	0.0015	0.052	CrCbGaD
Propiomazine—Chlorpromazine—BCHE—malignant glioma	0.00107	0.0371	CrCbGaD
Propiomazine—DRD1—Signaling Pathways—PTEN—malignant glioma	3.78e-05	0.000104	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—STAT3—malignant glioma	3.76e-05	0.000104	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	3.76e-05	0.000104	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—MMP9—malignant glioma	3.76e-05	0.000104	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	3.75e-05	0.000103	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—VEGFA—malignant glioma	3.75e-05	0.000103	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—PTEN—malignant glioma	3.73e-05	0.000103	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	3.73e-05	0.000103	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PIK3CD—malignant glioma	3.72e-05	0.000103	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—KRAS—malignant glioma	3.71e-05	0.000102	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	3.71e-05	0.000102	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—STAT3—malignant glioma	3.71e-05	0.000102	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—PIK3CA—malignant glioma	3.7e-05	0.000102	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	3.7e-05	0.000102	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	3.7e-05	0.000102	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—AKT1—malignant glioma	3.69e-05	0.000102	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	3.69e-05	0.000102	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MDM2—malignant glioma	3.69e-05	0.000102	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	3.68e-05	0.000101	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—RAF1—malignant glioma	3.67e-05	0.000101	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	3.67e-05	0.000101	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	3.66e-05	0.000101	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	3.65e-05	0.000101	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—KRAS—malignant glioma	3.65e-05	0.000101	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—KRAS—malignant glioma	3.65e-05	0.000101	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—AKT1—malignant glioma	3.64e-05	0.0001	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—KRAS—malignant glioma	3.63e-05	0.0001	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	3.63e-05	0.0001	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—FGF2—malignant glioma	3.63e-05	0.0001	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	3.63e-05	0.0001	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—KRAS—malignant glioma	3.62e-05	9.99e-05	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	3.62e-05	9.98e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CXCL8—malignant glioma	3.6e-05	9.92e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—KRAS—malignant glioma	3.59e-05	9.89e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—VEGFA—malignant glioma	3.59e-05	9.89e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	3.59e-05	9.89e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	3.58e-05	9.86e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—FGF2—malignant glioma	3.57e-05	9.85e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—FGF2—malignant glioma	3.57e-05	9.83e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—FGF2—malignant glioma	3.55e-05	9.8e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—STAT3—malignant glioma	3.55e-05	9.79e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—FGF2—malignant glioma	3.54e-05	9.77e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—FGF2—malignant glioma	3.51e-05	9.67e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—FGF2—malignant glioma	3.5e-05	9.65e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—MYC—malignant glioma	3.49e-05	9.63e-05	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	3.48e-05	9.59e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	3.45e-05	9.5e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—MYC—malignant glioma	3.45e-05	9.5e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CASP3—malignant glioma	3.45e-05	9.5e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IL2—malignant glioma	3.44e-05	9.48e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—VEGFA—malignant glioma	3.42e-05	9.42e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—EGFR—malignant glioma	3.42e-05	9.42e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	3.41e-05	9.41e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MDM2—malignant glioma	3.4e-05	9.37e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—RAF1—malignant glioma	3.39e-05	9.34e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—STAT3—malignant glioma	3.38e-05	9.33e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—VEGFA—malignant glioma	3.37e-05	9.3e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—EGFR—malignant glioma	3.37e-05	9.29e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	3.36e-05	9.25e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—ERBB2—malignant glioma	3.35e-05	9.24e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	3.35e-05	9.23e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MDM2—malignant glioma	3.34e-05	9.22e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—STAT3—malignant glioma	3.34e-05	9.2e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	3.34e-05	9.2e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MDM2—malignant glioma	3.34e-05	9.2e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—PTEN—malignant glioma	3.33e-05	9.19e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—RAF1—malignant glioma	3.33e-05	9.19e-05	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	3.33e-05	9.18e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	3.33e-05	9.18e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MDM2—malignant glioma	3.33e-05	9.17e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—RAF1—malignant glioma	3.32e-05	9.17e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MDM2—malignant glioma	3.32e-05	9.14e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—RAF1—malignant glioma	3.31e-05	9.14e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	3.31e-05	9.11e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—RAF1—malignant glioma	3.3e-05	9.11e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—MYC—malignant glioma	3.3e-05	9.1e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CASP3—malignant glioma	3.3e-05	9.09e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	3.3e-05	9.09e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	3.3e-05	9.09e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IL2—malignant glioma	3.29e-05	9.08e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—ERBB2—malignant glioma	3.29e-05	9.07e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	3.29e-05	9.06e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MDM2—malignant glioma	3.28e-05	9.05e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—ERBB2—malignant glioma	3.28e-05	9.04e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MDM2—malignant glioma	3.27e-05	9.03e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—RAF1—malignant glioma	3.27e-05	9.02e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—ERBB2—malignant glioma	3.27e-05	9.01e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	3.26e-05	8.99e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—MMP9—malignant glioma	3.26e-05	8.98e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	3.25e-05	8.97e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	3.25e-05	8.95e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PTEN—malignant glioma	3.24e-05	8.92e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	3.24e-05	8.92e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	3.24e-05	8.92e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—EGFR—malignant glioma	3.23e-05	8.9e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	3.23e-05	8.9e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—KRAS—malignant glioma	3.23e-05	8.9e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	3.23e-05	8.89e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	3.19e-05	8.81e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	3.19e-05	8.78e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—KRAS—malignant glioma	3.18e-05	8.78e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CXCL8—malignant glioma	3.18e-05	8.76e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	3.16e-05	8.71e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—MYC—malignant glioma	3.14e-05	8.67e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	3.13e-05	8.62e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CXCL8—malignant glioma	3.12e-05	8.6e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MMP9—malignant glioma	3.12e-05	8.59e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CXCL8—malignant glioma	3.11e-05	8.57e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—MYC—malignant glioma	3.1e-05	8.55e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CXCL8—malignant glioma	3.1e-05	8.54e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PTEN—malignant glioma	3.1e-05	8.54e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—EGFR—malignant glioma	3.08e-05	8.48e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	3.07e-05	8.46e-05	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	3.07e-05	8.46e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	3.06e-05	8.44e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—KRAS—malignant glioma	3.05e-05	8.41e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CASP3—malignant glioma	3.04e-05	8.38e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IL2—malignant glioma	3.04e-05	8.37e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—EGFR—malignant glioma	3.03e-05	8.37e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	3.02e-05	8.33e-05	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	3.02e-05	8.32e-05	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	3.01e-05	8.31e-05	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	3e-05	8.28e-05	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	2.99e-05	8.25e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CASP3—malignant glioma	2.99e-05	8.25e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IL2—malignant glioma	2.99e-05	8.24e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CASP3—malignant glioma	2.99e-05	8.23e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IL2—malignant glioma	2.98e-05	8.22e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CASP3—malignant glioma	2.98e-05	8.2e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IL2—malignant glioma	2.97e-05	8.19e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CASP3—malignant glioma	2.97e-05	8.18e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—PIK3CA—malignant glioma	2.97e-05	8.17e-05	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	2.97e-05	8.17e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IL2—malignant glioma	2.96e-05	8.17e-05	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	2.96e-05	8.15e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CASP3—malignant glioma	2.94e-05	8.1e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IL2—malignant glioma	2.93e-05	8.09e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	2.93e-05	8.08e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	2.93e-05	8.06e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IL2—malignant glioma	2.93e-05	8.06e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	2.92e-05	8.06e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—KRAS—malignant glioma	2.91e-05	8.01e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—STAT3—malignant glioma	2.9e-05	7.98e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MMP9—malignant glioma	2.87e-05	7.92e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—TP53—malignant glioma	2.87e-05	7.91e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—KRAS—malignant glioma	2.87e-05	7.9e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PTEN—malignant glioma	2.86e-05	7.88e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—TP53—malignant glioma	2.83e-05	7.8e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MMP9—malignant glioma	2.83e-05	7.79e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MMP9—malignant glioma	2.82e-05	7.78e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MMP9—malignant glioma	2.81e-05	7.75e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PTEN—malignant glioma	2.81e-05	7.75e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PTEN—malignant glioma	2.81e-05	7.73e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MMP9—malignant glioma	2.8e-05	7.73e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	2.8e-05	7.72e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	2.8e-05	7.72e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PTEN—malignant glioma	2.8e-05	7.71e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—AKT1—malignant glioma	2.79e-05	7.68e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PTEN—malignant glioma	2.79e-05	7.68e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MMP9—malignant glioma	2.78e-05	7.65e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	2.77e-05	7.64e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	2.77e-05	7.63e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PTEN—malignant glioma	2.76e-05	7.61e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	2.75e-05	7.59e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	2.74e-05	7.56e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—AKT1—malignant glioma	2.74e-05	7.54e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—AKT1—malignant glioma	2.73e-05	7.52e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—AKT1—malignant glioma	2.72e-05	7.5e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—TP53—malignant glioma	2.71e-05	7.47e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	2.69e-05	7.42e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—MYC—malignant glioma	2.69e-05	7.42e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	2.69e-05	7.4e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—PIK3CA—malignant glioma	2.67e-05	7.36e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	2.63e-05	7.26e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—EGFR—malignant glioma	2.63e-05	7.25e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—TP53—malignant glioma	2.58e-05	7.12e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—VEGFA—malignant glioma	2.58e-05	7.11e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MYC—malignant glioma	2.58e-05	7.1e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—STAT3—malignant glioma	2.56e-05	7.04e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—TP53—malignant glioma	2.55e-05	7.02e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	2.54e-05	7e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—VEGFA—malignant glioma	2.53e-05	6.98e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—VEGFA—malignant glioma	2.53e-05	6.96e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	2.52e-05	6.94e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—VEGFA—malignant glioma	2.52e-05	6.94e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—STAT3—malignant glioma	2.51e-05	6.93e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—STAT3—malignant glioma	2.51e-05	6.92e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—STAT3—malignant glioma	2.5e-05	6.89e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	2.49e-05	6.87e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—STAT3—malignant glioma	2.49e-05	6.87e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	2.49e-05	6.85e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—KRAS—malignant glioma	2.49e-05	6.85e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—STAT3—malignant glioma	2.47e-05	6.8e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	2.46e-05	6.79e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—AKT1—malignant glioma	2.42e-05	6.68e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—AKT1—malignant glioma	2.39e-05	6.59e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	2.38e-05	6.56e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MYC—malignant glioma	2.37e-05	6.54e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—PIK3CA—malignant glioma	2.35e-05	6.48e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MYC—malignant glioma	2.34e-05	6.44e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MYC—malignant glioma	2.33e-05	6.43e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MYC—malignant glioma	2.32e-05	6.41e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—EGFR—malignant glioma	2.32e-05	6.4e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MYC—malignant glioma	2.32e-05	6.38e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MYC—malignant glioma	2.29e-05	6.32e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—AKT1—malignant glioma	2.29e-05	6.31e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MYC—malignant glioma	2.29e-05	6.31e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—EGFR—malignant glioma	2.29e-05	6.3e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	2.28e-05	6.3e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—EGFR—malignant glioma	2.28e-05	6.29e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—EGFR—malignant glioma	2.27e-05	6.27e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—EGFR—malignant glioma	2.27e-05	6.25e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—EGFR—malignant glioma	2.24e-05	6.18e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	2.24e-05	6.17e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TP53—malignant glioma	2.21e-05	6.09e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—KRAS—malignant glioma	2.19e-05	6.05e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	2.19e-05	6.03e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—AKT1—malignant glioma	2.18e-05	6.01e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—KRAS—malignant glioma	2.16e-05	5.95e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—KRAS—malignant glioma	2.15e-05	5.94e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—AKT1—malignant glioma	2.15e-05	5.93e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—KRAS—malignant glioma	2.15e-05	5.92e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—KRAS—malignant glioma	2.14e-05	5.9e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—KRAS—malignant glioma	2.12e-05	5.84e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TP53—malignant glioma	2.11e-05	5.83e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	2.11e-05	5.83e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	2.02e-05	5.56e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.98e-05	5.47e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	1.98e-05	5.45e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	1.97e-05	5.44e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	1.97e-05	5.42e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TP53—malignant glioma	1.95e-05	5.37e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	1.95e-05	5.37e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	1.94e-05	5.35e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—AKT1—malignant glioma	1.92e-05	5.3e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TP53—malignant glioma	1.92e-05	5.29e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TP53—malignant glioma	1.91e-05	5.28e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TP53—malignant glioma	1.91e-05	5.26e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TP53—malignant glioma	1.9e-05	5.24e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TP53—malignant glioma	1.88e-05	5.19e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TP53—malignant glioma	1.88e-05	5.18e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.87e-05	5.14e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	1.79e-05	4.92e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—AKT1—malignant glioma	1.65e-05	4.54e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.62e-05	4.47e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—AKT1—malignant glioma	1.62e-05	4.46e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—AKT1—malignant glioma	1.61e-05	4.44e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—AKT1—malignant glioma	1.61e-05	4.43e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—AKT1—malignant glioma	1.59e-05	4.38e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	1.59e-05	4.37e-05	CbGpPWpGaD
